IBUPROFEN | A075682 | DR REDDYS LABORATORIES INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Hyman, Phelps & McNamara, P.C. FDA-2026-P-3631 Hyman, Phelps & McNamara, P.C. filed this suitability petition on behalf of a client requesting that the FDA declare Ibuprofen Tablets, 1,200 mg, suitable for submission as an ANDA under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act, with the RLD being MOTRIN (ibuprofen) Tablets a | Suitability | 2026-04-02 | Open | Hyman |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.